Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 January 2019

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 3 January 2019

   Introduced

   Introduced in House

   Source: IntroReferral

3. 3 January 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 25 January 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 January 2019 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 January 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 January 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 3 January 2019

  Open at official source

Sponsors

• Al Green · D · Sponsor
• Sheila Jackson Lee · D · Cosponsor
• Rep. Veasey, Marc A. [D-TX-33] · D · Cosponsor
• · hsif00 · Standing

Related records

• related to → Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
• related to ← Byron Nash Renal Medullary Carcinoma Awareness Act of 2017